Conover Charles (CIK 0001538563)

Latest company ownership

ENZN - ENZON PHARMACEUTICALS, INC.
Role: SVP, R&D Program Management
Shares held
74,793
Last filed at
Jan 25, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 5, 2012 Jun 6, 2012 ENZON PHARMACEUTICALS, INC. SVP, R&D Program Management Sell 22.5 -25,000 -30.41% ✗ $169.5K